Maribel Ciampitti, M.S. CCC-SLP, Author at Dysphagia Cafe

1 POSTS 0 COMMENTS

Maribel Ciampitti received her bachelor’s and master’s degrees in Speech-Language Pathology from the Indiana University of Pennsylvania. She has been a certified speech-language pathologist since 1998 and has worked in a variety of settings with both pediatric and adult populations. Her expertise is in the evaluation and management of communication and swallowing disorders in medically complex adult and geriatric patients, requiring tracheostomy and ventilator support. Currently, Maribel is the Clinical Rehab Supervisor-TCU at UF Health Jacksonville.

Impact of mechanical ventilation on swallowing: Early Intervention-A speech-language pathologist’s perspective

Maribel Ciampitti, M.S. CCC-SLP - July 28, 2019

Scroll for Important Safety Information

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.